Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Krystal Biotech (KRYS) Inventory Average: 2023-2025

Historic Inventory Average for Krystal Biotech (KRYS) over the last 2 years, with Sep 2025 value amounting to $34.3 million.

  • Krystal Biotech's Inventory Average rose 123.25% to $34.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $34.3 million, marking a year-over-year increase of 123.25%. This contributed to the annual value of $16.7 million for FY2024, which is N/A change from last year.
  • Per Krystal Biotech's latest filing, its Inventory Average stood at $34.3 million for Q3 2025, which was up 12.61% from $30.5 million recorded in Q2 2025.
  • Over the past 5 years, Krystal Biotech's Inventory Average peaked at $34.3 million during Q3 2025, and registered a low of $6.1 million during Q4 2023.
  • Over the past 3 years, Krystal Biotech's median Inventory Average value was $19.0 million (recorded in 2024), while the average stood at $19.7 million.
  • Data for Krystal Biotech's Inventory Average shows a peak YoY spiked of 267.68% (in 2024) over the last 5 years.
  • Krystal Biotech's Inventory Average (Quarterly) stood at $6.1 million in 2023, then soared by 267.68% to $22.5 million in 2024, then surged by 123.25% to $34.3 million in 2025.
  • Its Inventory Average stands at $34.3 million for Q3 2025, versus $30.5 million for Q2 2025 and $28.2 million for Q1 2025.